Victory Portfolios IV has recently submitted its NPORT-P report, which provides a comprehensive overview of the financial status and investment strategies of its Victory High Income Municipal Fund. This filing is particularly significant as it offers insights into the fund's asset management and performance metrics, which are critical for investors and analysts in the investment sector.
The filing, dated October 29, 2026, reveals that the Victory High Income Municipal Fund has total assets amounting to approximately $569.5 million, with total liabilities of about $3.6 million. This results in net assets of approximately $565.9 million. Such figures are essential indicators of the fund's financial health and operational efficiency.
Background
Victory Portfolios IV, an investment entity, is known for managing various funds, including the Victory High Income Municipal Fund. The company is incorporated in Delaware and has a fiscal year ending on October 31. The latest filing is part of a series of recent submissions, all dated October 29, 2026, which include multiple NPORT-P forms, indicating ongoing updates to the fund's financial reporting.
What the Filing Says
The NPORT-P filing includes key financial metrics and highlights the fund's investment strategies. The report states, "The total assets of the fund are $569,497,572.48, while total liabilities stand at $3,587,573.49, resulting in net assets of $565,909,998.99." This transparency allows stakeholders to assess the fund's performance and its ability to manage assets effectively.
Impact
The information provided in this filing could significantly affect various stakeholders, including current and potential investors, financial analysts, and competitors within the municipal investment space. By understanding the fund's asset allocation and performance metrics, investors can make informed decisions regarding their investments.
What's Next
The filing does not specify what happens next, leaving stakeholders to anticipate future updates or strategic shifts from Victory Portfolios IV.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






